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ABSTRACT
Ping-Wei San (PWS), a Chinese medical decoction, was used to improve digestive absorption. This study was aimed to determine
whether treatment with PWS reduce gastric ulceration induced by indomethacin and influencing its anti-inflammatory effect. PWS was
extracted with boiling water and the decoction was freeze-dried into powder (H-PWS). The amounts of glycyrrhizin and hesperidin in
H-PWS were analyzed by a HPLC method to be 38 and 19 mg/g, respectively. Co-administration of H-PWS resulted in a dose-dependent
inhibition of indomethacin-induced gastric mucosal cell death. H-PWS (200 mg/kg) also alleviated the indomethacin-induced gastric
ulcer in male Wistar rats in vivo. The inhibition effects of NO and PGE2 production were enhanced by indomethancin co-treatment with
H-PWS from LPS-stimulated RAW 264.7 cells. H-PWS (200 mg/kg) also augmented the anti-inflammatory effect of indomethacin in
1% carrageen-induced paw edema. Moreover, H-PWS co-treatment with indomethacin produced a lower PGE2 level in serum than only
indomethacin. Based on the results, co-treatment with H-PWS reduced the occurrence of indomethacin-induced gastric ulcers without
affecting the anti-inflammatory effect of indomethacin. Therefore, we suggested that H-PWS can be developed as an anti-ulcer drug
and H-PWS could be taken with indomethacin to decrease ulceration.
Key words: Ping-Wei San, Indomethacin, Gastric ulcer, Anti-inflammation

INTRODUCTION
Ping-Wei San has been used since 1107 AD, and its
pharmacologic functions have been well documented in the
Chinese literatures. The Chinese traditional medicine book,
Tai Ping Huei Min Ho Chi Chu Fang, describes the gastric
symptoms cured by Ping-Wei San(1). These are now classified as chronic superficial or atrophic gastritis, acute infectious enteritis, and ulcer-active colitis. In this study, modern
experimental techniques were employed to investigate the
traditional applications of Ping-Wei San.
Ping-Wei San is made from Atractylodes, magnolia
bark, citrus, licorice, ginger and jujubes (Table 1)(2-10). Each
herb in the formula has various pharmacological roles. For
examples, Atractylodes remove fluids accumulated in the
stomach. Magnolia bark, citrus, and licorice improve gastric
functions. Ginger treats nausea and vomiting. Moreover,
licorice and jujubes aid the interaction among the herbs and
* Author for correspondence. Tel: +886-2-27361661 ext. 6161;
Fax: +886-2-27329368; E-mail: crystal@tmu.edu.tw

add sweet taste(1). Western pharmacological studies show
that atractylenolides I, II, and III of Atractylodes, honokiol
of magnolia bark, hesperidin of citrus, glycyrrhizin of licorice, 6-gingerol of ginger, and oleanolic acid of jujubes all
show anti-inflammatory effects as shown in Table 1(11-15).
However, the anti-ulcer effects of Ping-Wei San were not
explored with pharmacological experiments or clinical
studies(16).
Indomethacin, one of the non-steroid anti-inflammatory
drugs (NSAID), is widely used to treat rheumatoid arthritis,
osteoarthritis and chronic pain. However, indomethacin will
induce clinically significant ulceration, bleeding, and peptic
ulceration by inhibiting prostaglandin biosynthesis(17). The
ulcer occurrence rate is 15 - 20% in patients taking NSAIDs
for an extended period. Cyclooxygenase II (COX II) inhibitors (celecoxib and nabumetone et al.) were developed as
NSAIDs to decrease ulcer formation(17). However, COX II
inhibitors increased the rate of cardiovascular disease and
their anti-inflammation effects were inferior to selective
COX I inhibitors (aspirin and indomethacin)(18-20). The
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Table 1. Composition and characteristics of Ping-Wei San
Effects from
scientific reports

English
name

Parts used

Approx %
of FHFa

Marker
substances

Traditional description
of functionb

Atractylodes lancea
(Thunb.) DC.

Atractylodes

rhizome

8

atractylenolide
III

Aromatic and
damp-resolving herb

gastroprotection and
anti-inflammation

Magnolia officinalis
Rehd. et Wils.

Magnolia

bark

5

honokiol

Aromatic and
damp-resolving herb

anti-tumor and
anti-inflammation

(2,3)

Citrus

peel

5

hesperidin

Qi-regulating herb

anti-oxidation and
anti-inflammation

(4)

Glycyrrhiza uralensis
Fischer

Licorice

root

3

glycyrrhizin

Qi-tonifying herb

Immunoregulation
and anti-inflammation

(5,6)

Zingiber officinale
Rosc.

Ginger

rhizome

3

6-gingerol

Herb for relieving
exterior syndromes

anti-oxidation and
anti-inflammation

(7,8)

Ziziphus jujube Mill.

Jujubes

fruit

2

oleanolic acid

Qi-tonifying herb

anti-inflammation

(9)

Botanical name

Citrus reticulata
Blanco

a

References
(1)

Approximate amount expressed as the percentage of the total fixed multiple herbal formula (FHF) content.
The traditional description from Chinese medical dictionaries.

b

problem of NSAID induced-gastric ulcers has not been
resolved. For this reason, we chose indomethacin as a gastric
ulcer inducer and study the relationship between Ping-Wei
San and indomethacin.
The aims of this study were to determine whether the
treatment with Ping-Wei San reduces gastric ulceration
induced by indomethacin and enhances the anti-inflammatory effects of indomethacin. We thus offer the scientific
evidence of Ping-Wei San application in gastric ulcer and to
establish evaluation strategies for the therapy.

MATERIALS AND METHODS
I. Chemicals and Reagents
HPLC-grade acetonitrile and indomethacin were
purchased from Merck (Darmstadt, Germany). Glycyrrhizin and hesperidin of purity higher than 99.0% were
from Nacalai Tesque, Inc. (Japan) and Extrasynthese, Inc.
(France), respectively. Penicillin-streptomycin, trypsinEDTA and fetal bovine serum (FBS) were from Gibco
(Gibco-BRL, UK). Dimethyl sulfoxide (DMSO) and 3-(4,
5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) were from Sigma Aldrich (St. Louis, MO, USA).
Cell culture medium DMEM/Ham’s F-12 1 : 1 (DMEM/F12)
was purchased from Gibco (Gibco-BRL). The Millipore
Milli-RO system (Milli-QRG, USA) was used to prepare
purified and deionized water.
II. Animals
Adult male Wistar rats weighing about 250 ± 10 g were
purchased from the BioLASCO Taiwan Co., Ltd. and kept
on a 12 : 12-h, day-night cycle. Animals were maintained

in polycarbonate cages at 21 ± 2°C and provided food and
water ad libitum. All experimental procedures involving
animals followed the ethical regulations of Taipei Medical
University (No.LAC-97-0007).
III. Preparation of the Aqueous Extracts of Ping-Wei San
(H-PWS)
The principal herbs of Ping-Wei San including Atractylodes (Compositae), magnolia bark (Magnoliaceae), citrus
(Rutaceae), licorice (Leguminosae), ginger (Zingiberaceae), and jujubes (Rhamnaceae) were purchased from a
traditional medicine store in Taipei, Taiwan. Table 1 lists
the constituents and their proportions used to prepare the
Ping-Wei San according to the Unified Formula announced
by the Committee on Chinese Medicine and Pharmacy of the
Department of Health in Taiwan. The herbs were immersed
in deionized water and boiled until the volume was reduced
by half. The extract was then filtered and freeze-dried. The
extraction yielded approximately 21.6% (w/w).
IV. Analysis of the Marker Substances in H-PWS
A Shimadzu LC-2010C HT liquid chromatography
system (Kyoto, Japan) was used in this study. Peak areas
were calculated using Shimadzu LC solution software.
The mobile phase was composed of 0.05% trifluoroacetic
acid/acetonitrile (v/v) with gradient elution (0 min, 87 : 13;
30 min, 70 : 30; 60 min, 0 : 100). A Purospher STAR RP-18e
reversed-phase column (250 × 4 mm i.d.) and a Purospher
STAR RP-18e guard column (4 × 4 mm i.d.) (Merck, Darmstadt, Germany) were used. The flow-rate was 1.0 mL/min
and UV absorbance detection was set at 254 and 280 nm.
The injection volume was 10 µL. The column temperature
was maintained at 40°C. The following compounds were
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V. Gastroprotection Assay of Ping-Wei San Co-cultured with
Indomethacin
(I) In Vitro Assay: Indomethacin Induced Death in Gastric
Mucosal Cells of Wistar Rats
The isolation of gastric mucosal (GM-R) cells from the
stomach tissue of Wistar rats was performed in accordance
with previous study(2). The GM-R cells were confirmed by
Periodic acid-Schiff (PAS) staining and cultured in DEME/
F12 containing 10% FBS, 100 mg/L streptomycin, and 100
IU/mL penicillin. GM-R cells from passages 3 - 5 were used
for the experiments. GM-R cells (1 × 105 cells/mL) were
seeded on a 24-well plate for one day. When the GM-R cells
adhered to the cultured plates, they were treated with indomethacin, H-PWS, and indomethacin co-treated H-PWS.
Cell viability was determined by MTT assay. The optical
density was measured at 570 nm on a μQuant spectrophotometer (BioTek, USA).
(II) In Vivo Assay: Indomethacin Induced Acute Gastric
Ulcer in Wistar Rats
The gastroprotective effects of H-PWS were investigated by its effect on indomethacin-induced acute gastric
ulcers in the Wistar rats. After fasting for 24 h except for
water, the H-PWS, dissolved in deionized water, was administered p.o. at 50 and 200 mg/kg, while was 30 min before
the rats were given p.o. indomethacin (40 mg/kg). Deionized
water was used for the control group. The rats were sacrificed after 4 and 6 h of treatment with indomethacin. The
stomach was removed, opened along the greater curvature
and washed with PBS. The ulcerated area of the stomach
was measured from the taken pictures. The lesions of gastric
ulcer were assessed with Scalar Digital Scale 1.0E software
(Scalar Corporation, Tokyo, Japan). After scoring the ulcerated area, the fundic stomach was fixed in 10% paraformaldehyde, gradually dehydrated in ethanol, and embedded
in paraffin. Sections (5 μm) were cut using a microtome,
stained with hematoxylin and eosin (H & E), and observed
under a light microscope.

3.7 g/L sodium bicarbonate, and maintained at 37°C and 5%
CO2. RAW 264.7 cells (4.0 × 105 cells/mL) were placed in
a 96-well plate and stimulated with 500 ng/mL LPS as in
the in vitro assay. After 18 h, the amount of nitrite in the
supernatant was determined with Griess reagent (1% sulphanilamide and 0.1% naphthyletylenediamine dihydrochloride
in 2% H3PO4), and the absorption was measured at 530 nm
on a μQuant spectrophotometer (BioTek, USA). The PGE2
concentrations in the cell culture mediums were measured
using a PGE2 ELISA kit (Assay Designs, Michigan, USA).
The viability of RAW 264.7 cells was measured using the
MTT assay.
(II) In Vivo Assay: Carrageenan-Induced Paw Edema in
Wistar Rats
Edema in the left hind paw of the Wistar rats was
induced by injection of 0.1 mL of 1% (w/v) carrageenan from
Sigma in saline into the subplantar region. The perimeter of
the paw was measured 1 h before the injection and hourly
for 1, 3, and 5 h after the injection using a plethysmometer
(Model 7140, Ugo Basile, Italy). One hour before the injection, the H-PWS were given orally, as in the in vivo assay.
The control group was given deionized water. After 6 h, the
mice were sacrificed and the serum was collected for the
PGE2 measurement.

(A)

400

300

mAU

identified in H-PWS: licorice-glycyrrhizin with a retention
time (Rt) of 42.18 min at 254 nm and citrus-hesperidin with
Rt of 21.57 min at 280 nm (Figure 1).

Glycyrrhizin

200

100

0

0

10

(I) In Vitro Assay: LPS Induced PGE2 Production from RAW
264.7 Cells
RAW 264.7 cells, a murine macrophage cell line,
were obtained from American Type Cell Culture (ATCC
no. TIB-71; Rockville, MD, USA). Cells were cultured in
DMEM supplemented with 10% FBS, 1% L-glutamine, and
1% penicillin-streptomycin. They were adjusted to contain
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VI. Anti-Inflammatory Assay of Ping-Wei San Co-Cultured
with Indomethacin
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Figure 1. HPLC fingerprints of H-PWS for the detection of glycyrrhizin and hesperidin using two UV wavelengths, 254 (A) and 280 (B)
nm, respectively.
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VII. Statistical Analysis
The data are presented as the mean and standard deviation (SD). Significance was calculated using Student’s t-test.
Differences were considered significant for p values < 0.05.

RESULTS
I. Concentrations of the Marker Substances in H-PWS
The marker substances, glycyrrhizin and hesperidin, (Table 1) in H-PWS were analyzed and quantified
with HPLC. Peak purity of two peaks (Rt 21. 57 min and
42.18 min) was calculated using Shimadzu Class-VP version:
6.14 SP1 (Shimadzu, Kyoto, Japan). The peak purity indices
of hesperidin and glycyrrhizin were 0.9998 and 1.0000,
respectively. The calibration curves of the method displayed
good linearity by a second order polynomial function (r 2).
The r 2 of glycyrrhizin was 0.9993 in the concentration range
of 0.0313 - 0.5 mg/mL and that of hesperidin was 0.9889 in
the range of 7.813 - 125.0 μg/mL. The relative standard deviation (RSD) of the method was on average below 5% for the
intraday and interday analysis of hesperidin, while the RSDs
of glycyrrhizin were 4.0 and 7.9%, respectively (Table 2).
The results showed that the method could be applied to
analyze glycyrrhizin and hesperidin. The glycyrrhizin and

hesperidin concentrations in H-PWS were found to be 38 and
19 mg/g, respectively (Table 2).
II. Gastroprotective Effects of H-PWS Co-Treatment with
Indomethacin
H-PWS under 5 mg/mL showed no cytotoxicity on
GM-R cells for 24 h, but cytotoxicity of indomethacin
were dose-dependent at 0.25 - 1 mM (Figure 2). The IC50
value of indomethacin was 0.50 ± 0.01 mM, therefore, 0.5
mM was used for induced cytotoxicity. GM-R cells were
co-treated with H-PWS and 0.5 mM indomethacin. H-PWS
significantly reduced the cytotoxicity of indomethacin in a
dose-dependent manner (Figure 3). Next, Wistar rats were
administered p.o. at 50 and 200 mg/kg, immediately before
administration of indomethacin (40 mg/kg) for 30 min.
Histological inspection (Figure 4A) showed that indomethacin induced acute degeneration, necrotic erosion, bleeding,
and deep ulceration in the gastric tissues of the rats. However,
pre-treatment with H-PWS reduced the necrotic erosion of
gastric mucosa caused by indomethacin induction (Figure 4).
Morphological analysis found that indomethacin significantly induced lesions in gastric mucosa and increased the
ulcer area by 5 - 7% (Figure 4B). Pre-treatment with H-PWS
(200 mg/kg) significantly reduced the ulcer area to below 3%
in the indomethacin treated rats (Figure 4B). Furthermore,
the ulcer area percentage induced by indomethacin did not

Table 2. Variation and content assay of marker substances in H-PWS
Marker
substances

Calibration equation

Intraday (mg/mL)

Interday (mg/mL)

Correlation
coefficient (r2)

Mean ± SD

RSD%

Mean ± SD

RSD%

Contents
(mg/g)

Glycyrrhizin

y = 3897731.9x + 657.5

0.9993

0.532 ± 0.021

4.030

0.537 ± 0.042

7.904

38

Hesperidin

y = 1732538.9x + 55121.0

0.9889

0.059 ± 0.001

1.249

0.056 ± 0.001

2.599

19

100

120

Cytotoxicity index (%)

Cytotoxicity index (%)

100
80
60
40

60
40
a
20
a

20
0

80

0
0.25

0.5

1

Concentration of indomethacin (mM)

Figure 2. The cytotoxicity effects of indomethacin were dose-dependent. Values are given in percentage of cytotoxicity compared to the
blank (cells only). Bars represent the mean ± SD of at least three independent experiments, each performed in triplicate.

0

0.625

1.25

a
2.5

H-PWS (mg/mL)

Indomethacin (0.5 mM)

Figure 3. The cytotoxicity effects of H-PWS co-treatment with 0.5
mM indomethacin. Values are given in percentage of cytotoxicity
compared to the blank (cells only). Bars represent the mean ± SD of
at
least three independent experiments, each performed in triplicate.
a
Statistically significant difference from the indomethacin group
p < 0.01.
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(A)
Indomethacin (40 mg/kg)
0

Sham

50

H-PWS (mg/kg)

200

100 x

100x

100x

100x

400x

400x

400x

400x

Ulcer area percentage (%)

(B) 10
4 hr
6 hr

8

6

4

a

a

2

0

0

50

200

H-PWS (mg/kg)

Indomethacin (40 mg/kg)

alter significantly after 4 h and 6 h. The results indicated that
H-PWS can alleviate indomethacin-induced gastric ulcers.
III. Anti-Inflammatory Effects of H-PWS Co-Treatment with
Indomethacin
NO and PGE2 were the inflammatory parameters
induced by LPS in RAW 264.7 cells. H-PWS did not inhibit
the production of NO and PGE2 in LPS-induced RAW 264.7
cells (data not shown). NO production was not affected by
indomethancin in LPS-induced RAW 264.7 cells. NO inhibition was enhanced by H-PWS co-treatment, however the
inhibition percentage was still lower than 50% (Figure 5A).
Moreover, although PGE2 production was significantly
inhibited by indomethacin and further inhibited by H-PWS
co-treatment (Figure 5B), PGE2 inhibition (%) did not
significantly differ between indomethacin and H-PWS
co-treatment groups.

Figure 4. Histological analysis (A) and percentage of ulcer formation
(B) for indomethacin-induced gastric ulcers and H-PWS gastroprotection. The gastric specimen was stained with hematoxylin and eosin. In
the control group, gastric mucosa showed bleeding, necrosis erosion,
acute degeneration, and deep ulceration (the region above the dotted
line; black arrow). After treatment with H-PWS, numerous proliferated mucosal cells were found rejuvenating the mucosal layer (black
triangle). Values represent the mean of five animals for each group. a
Statistically significant difference from the indomethacin group at the
same time, p < 0.05. (100x and 400x magnification)

The in vivo assay showed that the carrageenan-induced
paw edema of the rats was not significantly inhibited by
H-PWS after treatment (data not shown). Moreover, indomethacin could significantly inhibit paw edema after 3 h
treatment, while H-PWS co-treatment did not decrease the
anti-inflammatory effect (Figure 6A). Moreover, indomethacin co-treatment with H-PWS more significantly inhibited
carrageenan-induced paw edema than indomethacin alone
at 1 h and 5 h. The serum of the tested rats was measured
using a PGE2 EIA kit after 6 h of indomethacin treatment.
Figure 6B shows that H-PWS enhanced PGE2 inhibition of
indomethacin in a dose-dependent manner.

DISCUSSION
Ping-Wei San is composed of six kinds of medical
herbs. Two compounds from these herbs, glycyrrhizin and
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hesperidin, exerted anti-inflammatory effects(19,21) and
could be detected in H-PWS by high-performance liquid
chromatography (Figure 1). The amount of glycyrrhizin
and hesperidin in H-PWS is used as marker for the quality
control of the decoction.
The anti-ulcer effects of several herbs used in Chinese
medicine have been reported(21-22). The animal model
for NSAID induced-gastric ulcers using rat is well established and has been applied in the development of antiulcer drugs(23). We also discussed the anti-inflammatory
effects of indomethacin in correlation with Ping-Wei San.
The results showed significant reduction in indomethacin
induced-gastric mucosa cell damage (Figure 3), ulceration,
and bleeding in Wistar rats (Figure 4) in a dose-dependent
manner. Ping-Wei San showed gastroprotective effects and
has the potential to be an anti-ulcer drug. We also studied
whether Ping-Wei San influences the anti-inflammatory
effects of indomethacin. In the in vitro study, H-PWS did not

inhibit NO and PGE2 production in LPS induced-RAW 264.7
cells. However, in co-treatment with indomethacin, NO and
PGE2 production was inhibited. Moreover, H-PWS co-treatment with indomethacin inhibited paw edema and the PGE2
level more significantly than indomethacin. The data suggest
that H-PWS did not impede the anti-inflammatory effect of
indomethacin and could even prolong its efficacy. Several
herbs, Chinese medicine and natural products have been
reported to exert anti-ulcer activity by NSAIDs, ethanol, or
stress-induced animal models(19,24,25). However, few study
discussed the application of NSAIDs-herbs co-treatment. In
this study, we are the first to report H-PWS can be applied as
an anti-ulcer drug and it also enhanced the anti-inflammatory
effects of indomethacin. Therefore, we suggest that indomethacin can be taken with H-PSW to decrease ulceration.
Indomethacin induces gastric ulcers via the major
pathways, which include the inhibition of COX activity, the
inhibition of constitutive NO synthase (cNOS), enhanced

(A)

(A)
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a

Paw edema volume (mL)

NO inhibition (%)
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a

a
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0
H-PWS (µg/mL)
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PGE2 concentration (pg/mL)
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*
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Figure 5. Inhibitory effects of H-PWS co-treatment with indomethacin
on NO (A) and PGE2 (B) production by LPS-stimulated RAW 264.7
cells. Values are given in percentage of inhibition of NO concentration compared to the control (500 ng/mL LPS only). Bars represent the
mean ± SD of at least three independent experiments, each performed
in triplicate. a Statistically significant difference from the indomethacin
group, p < 0.005; * from the LPS-stimulated group, p < 0.05.

PGE2 concentration (pg/mL)
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b b
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b
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1
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5

Time (h)
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*

4

1 % Carrageenan
Indomethacin (40 mg/kg)
Indomethacin (40 mg/kg) + H-PWS (50 mg/kg)
Indomethacin (40 mg/kg) + H-PWS (200 mg/kg)

0

Indomethacin (0.5 µM)
(B)

5
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400
b

300
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0

0
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200

Indomethacin (40 mg/kg)

Figure 6. The anti-inflammatory effect of H-PWS on the paw perimeter (A) and PGE2 level (B) of carrageenan-induced paw edema after
H-PWS treatment for 6h. Values represent the mean of five animals
for each group. a Statistically significant difference from the indomethacin only group, p < 0.05; b: from the 1% carrageenan only group,
p < 0.05.
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inducible NOS, and direct cytotoxic effects on the epithelium(5,17). NO production from iNOS interacts with reactive
oxygen moiety and superoxide to form peroxynitrite, which
is highly cytotoxic and damages epithelial cells(5). The
acidic nature of NSAIDs can also kill epithelial cells(25).
Indomethacin did not inhibit NO production in LPS-induced
RAW 264.7 cells, but H-PWS co-treatment did (Figure 5).
Therefore, H-PWS enhanced the NO inhibition caused by
indomethacin and neutralized its acidic nature. Hence, the
inflammatory effects of indomethacin were not influenced
by H-PWS.
In this study, the interaction between indomethacin
and Ping-Wei San was investigated and H-PWS was found
to reduce the indomethacin-induced gastric ulcer and did
not influence anti-inflammatory effects of indomethacin.
The results offered the potential of Ping-Wei San and drugs
combination usages.
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